Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Rossi

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Bulletin Du Cancer|December 29, 2006
[Recommendation for clinical practice: use of PET-FDG in cancer of the kidney, prostate, testicles, and the urinary bladder]Patrick Bourguet, François Planchamp, Françoise Montravers, et al.
The French Journal of Urology|December 26, 2025
Prostatic enucleation vs. photoselective vaporization of prostate vs. simple prostatectomy: performance, functional results and complicationsLéa Perez, Bastien Gondran Tellier, Gilles Karsenty, et al.
The Journal of Urology|October 22, 2011
Incidence, risk profile and morphological pattern of lower extremity venous thromboembolism after urological cancer surgeryChristophe Clément, Pascal Rossi, Karim Aissi, et al.
Human Pathology|June 27, 2003
Neural cell adhesion molecule expression in renal cell carcinomas: relation to metastatic behaviorLaurent Daniel, Corinne Bouvier, Bruno Chetaille, et al.
Therapeutic Advances in Urology|December 22, 2018
Criteria for indication and treatment modification in a cohort of patients with prostate cancer treated with hormone therapyThierry Lebret, Alain Ruffion, Igor Latorzeff, et al.
World Journal of Urology|September 28, 2019
Comparison between Zumsteg classification and Briganti nomogram for the risk of lymph-node invasion before radical prostatectomyNicolas Branger, Géraldine Pignot, François Lannes, et al.
BJU International|August 20, 2011
Seminal vesicle invasion: what is the best adjuvant treatment after radical prostatectomy?Cyrille Bastide, Dominique Rossi, Eric Lechevallier, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|March 1, 2014
Quality of life of 1276 elderly patients with prostate cancer, starting treatment with a gonadotropin-releasing hormone agonist: results of a French observational studyThierry Lebret, Stéphane Culine, Jean-Louis Davin, et al.
Therapeutic Advances in Urology|December 2, 2014
Selection criteria for initiation and renewal of luteinizing hormone-releasing hormone agonist therapy in patients with prostate cancer: a French prospective observational studyThierry Lebret, Jean-Louis Davin, Christophe Hennequin, et al.
Cancers|January 1, 2021
Impact of Androgen Deprivation Therapy Associated to Conformal Radiotherapy in the Treatment of D'Amico Intermediate-/High-Risk Prostate Cancer in Older PatientsAnne-Laure Couderc, Emanuel Nicolas, Romain Boissier, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Bulletin Du Cancer|December 29, 2006
[Recommendation for clinical practice: use of PET-FDG in cancer of the kidney, prostate, testicles, and the urinary bladder]Patrick Bourguet, François Planchamp, Françoise Montravers, et al.
The French Journal of Urology|December 26, 2025
Prostatic enucleation vs. photoselective vaporization of prostate vs. simple prostatectomy: performance, functional results and complicationsLéa Perez, Bastien Gondran Tellier, Gilles Karsenty, et al.
The Journal of Urology|October 22, 2011
Incidence, risk profile and morphological pattern of lower extremity venous thromboembolism after urological cancer surgeryChristophe Clément, Pascal Rossi, Karim Aissi, et al.
Human Pathology|June 27, 2003
Neural cell adhesion molecule expression in renal cell carcinomas: relation to metastatic behaviorLaurent Daniel, Corinne Bouvier, Bruno Chetaille, et al.
Therapeutic Advances in Urology|December 22, 2018
Criteria for indication and treatment modification in a cohort of patients with prostate cancer treated with hormone therapyThierry Lebret, Alain Ruffion, Igor Latorzeff, et al.
World Journal of Urology|September 28, 2019
Comparison between Zumsteg classification and Briganti nomogram for the risk of lymph-node invasion before radical prostatectomyNicolas Branger, Géraldine Pignot, François Lannes, et al.
BJU International|August 20, 2011
Seminal vesicle invasion: what is the best adjuvant treatment after radical prostatectomy?Cyrille Bastide, Dominique Rossi, Eric Lechevallier, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|March 1, 2014
Quality of life of 1276 elderly patients with prostate cancer, starting treatment with a gonadotropin-releasing hormone agonist: results of a French observational studyThierry Lebret, Stéphane Culine, Jean-Louis Davin, et al.
Therapeutic Advances in Urology|December 2, 2014
Selection criteria for initiation and renewal of luteinizing hormone-releasing hormone agonist therapy in patients with prostate cancer: a French prospective observational studyThierry Lebret, Jean-Louis Davin, Christophe Hennequin, et al.
Cancers|January 1, 2021
Impact of Androgen Deprivation Therapy Associated to Conformal Radiotherapy in the Treatment of D'Amico Intermediate-/High-Risk Prostate Cancer in Older PatientsAnne-Laure Couderc, Emanuel Nicolas, Romain Boissier, et al.
Pageof 4